Cue Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	11.7	22.46	48.51	51.61	64.37	74.87
Short-Term Investments	6.97	-	-	24.68	-	10
Cash & Short-Term Investments	18.67	22.46	48.51	76.29	64.37	84.87
Cash Growth	-42.41%	-53.71%	-36.41%	18.52%	-24.15%	42.85%
Accounts Receivable	0.39	0.95	1.7	0.06	3.14	1.42
Other Receivables	1.89	-	-	-	-	-
Total Trade Receivables	2.28	0.95	1.7	0.06	3.14	1.42
Other Current Assets	4.86	1.73	1.24	0.84	0.95	1.24
Total Current Assets	25.81	25.14	51.45	77.19	68.47	87.53
Net Property, Plant & Equipment	4.81	4.84	7.12	10.7	11.92	8.88
Other Long-Term Assets	0.96	2.25	2.96	3.39	3.01	3.12
Total Assets	31.64	32.19	61.53	91.28	83.4	99.53
Accounts Payable	2.35	2.82	3.5	2.73	2.59	2.07
Accrued Expenses	1.87	2.91	4.14	3.55	4.62	2.79
Current Portion of Long-Term Debt	1.46	4.33	3.96	1.96	-	-
Current Portion of Leases	2.03	3.54	3.37	3.3	4.93	4.78
Unearned Revenue	7.82	0.09	2.11	-	0.65	6.68
Total Current Liabilities	15.52	13.69	17.08	11.55	12.79	16.32
Long-Term Debt	-	-	4.2	8.04	-	-
Long-Term Leases	2.68	1	3.16	6.02	5.12	2.37
Other Long-Term Liabilities	0.19	-	-	-	-	1.94
Total Long-Term Liabilities	2.87	1	7.36	14.05	5.12	4.31
Total Liabilities	18.4	14.69	24.45	25.6	17.91	20.62
Common Stock	0.08	0.06	0.05	0.04	0.03	0.03
Additional Paid-in Capital	383.22	359.3	338.23	316.19	262.91	232.16
Accumulated Other Comprehensive Income	-	-	-	-0.1	-	0.01
Retained Earnings	-370.05	-341.86	-301.19	-250.46	-197.45	-153.29
Shareholders' Equity	13.25	17.5	37.09	65.68	65.49	78.91
Total Liabilities & Equity	31.64	32.19	61.53	91.28	83.4	99.53
Total Debt	6.17	8.88	14.7	19.32	10.05	7.15
Net Cash (Debt)	12.5	13.58	33.82	56.97	54.32	77.72
Net Cash Growth	-7.98%	-59.84%	-40.64%	4.89%	-30.11%	44.97%
Net Cash Per Share	0.14	0.24	0.74	1.60	1.74	2.71
Book Value	13.25	17.5	37.09	65.68	65.49	78.91
Book Value Per Share	0.15	0.31	0.81	1.84	2.09	2.75
Tangible Book Value	13.25	17.5	37.09	65.68	65.49	78.91
Tangible Book Value Per Share	0.15	0.31	0.81	1.84	2.09	2.75

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q